Evidence map›Paper›PMID 34817844›Full record

ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2022

Successful treatment of acute-on-chronic liver failure secondary to alcoholic cirrhosis with glucocorticoids and albumin: a case report.

Jiuqin Zhou, Si Chen, Lin Zhang, Yongzhen Zhai

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jiuqin Zhou *Department of Infectious Disease, Shengjing Hospital of China Medical University, No.39 of Huaxiang Road, Tiexi District, Shenyang, 110022, Liaoning Province, China.
Si Chen *Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, Liaoning Province, China.
Lin ZhangDepartment of Infectious Disease, Shengjing Hospital of China Medical University, No.39 of Huaxiang Road, Tiexi District, Shenyang, 110022, Liaoning Province, China.
Yongzhen ZhaiDepartment of Infectious Disease, Shengjing Hospital of China Medical University, No.39 of Huaxiang Road, Tiexi District, Shenyang, 110022, Liaoning Province, China. zhaiyzaa@21cn.com.
China Medical University · CNFourth Affiliated Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucocorticoids are used as a first-line treatment for severe alcoholic hepatitis, and albumin reduces both the number of hospitalizations and mortality in patients with decompensated cirrhosis. However, for acute-on-chronic liver failure (ACLF), there is no definitive evidence that glucocorticoid therapy is beneficial. In this case report, we describe a male patient who developed into ACLF based on alcoholic cirrhosis, whose symptoms and clinical indicators continued to deteriorate after initial symptomatic treatment. The patient's condition gradually improved after low-dose glucocorticoid therapy, and long-term albumin supplementation resulted in a satisfactory outcome.

Indexed as

Acute-On-Chronic Liver FailureAlbuminsGlucocorticoidsHumansLiver CirrhosisLiver Cirrhosis, AlcoholicMaleAlbuminsGlucocorticoidsAcute-on-chronic liver failureAlbuminAlcoholic cirrhosisGlucocorticoidsSpontaneous bacterial peritonitis

Identifiers

PMID34817844
PMCPMC9114176
OpenAlexW3215506671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.